Literature DB >> 9147818

Transactivation of proenkephalin gene by HTLV-1 tax1 protein in glial cells: involvement of Fos/Jun complex at an AP-1 element in the proenkephalin gene promoter.

W Fu1, S R Shah, H Jiang, D C Hilt, H P Dave, J B Joshi.   

Abstract

The human T-cell lymphotropic virus type 1 (HTLV-1), an etiologic agent for adult T-cell leukemia, is strongly associated with tropical spastic paraparesis, a chronic neurological disease. The HTLV-1 genome encodes a protein, tax1, an autoregulator of enhanced viral RNA transcription, that also transactivates/represses certain cellular gene promoters. Enkephalins are opioid peptides that function as neurotransmitters and neuroimmunomodulators. We earlier reported that the proenkephalin gene is transactivated by tax1 protein in glial cells. The nucleotide sequence upstream of -190 base pairs in the proenkephalin gene promoter is necessary for maximal transactivation by tax1 while the sequence downstream of -190 bp confers modest activation by tax1. We investigated the cellular transcription factors in tax1 expressing glial cells that associate with the proenkephalin promoter and herein demonstrate the enhanced interaction and involvement of c-Fos/c-Jun proteins in the complexes formed at the AP-1 site. The HTLV-1 tax1 expressing stable glial cell lines produced functional tax1 protein that increased the expression of endogenous proenkephalin gene. The comparative electrophoretic mobility shift and 'supershift' analysis using specific antibodies indicated the enhanced presence of c-Fos and c-Jun proteins in the DNA: protein complex formed at the AP-1 site. The c-Fos protein expression significantly increased in the tax1 expressing glial cells. The tax1 induced c-Fos protein levels and the concurrently increased association of c-Fos/c-Jun transcription factors at the AP-1 site imply a strong functional significance in the activation of proenkephalin gene expression in tax1 expressing glial cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9147818     DOI: 10.3109/13550289709015789

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  6 in total

1.  Induction of lactoferrin gene expression in myeloid or mammary gland cells by human T-cell leukemia virus type 1 (HTLV-1) tax: implications for milk-borne transmission of HTLV-1.

Authors:  Masako Moriuchi; Hiroyuki Moriuchi
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

2.  HTLV-1 subgroups associated with the risk of HAM/TSP are related to viral and host gene expression in peripheral blood mononuclear cells, independent of the transactivation functions of the viral factors.

Authors:  Keiko Yasuma; Toshio Matsuzaki; Yoshihisa Yamano; Hiroshi Takashima; Masao Matsuoka; Mineki Saito
Journal:  J Neurovirol       Date:  2015-12-03       Impact factor: 2.643

3.  Human T-cell leukemia virus type 1 oncoprotein tax represses ZNF268 expression through the cAMP-responsive element-binding protein/activating transcription factor pathway.

Authors:  Di Wang; Ming-Xiong Guo; Hai-Ming Hu; Zhou-Zhou Zhao; Hong-Ling Qiu; Huan-Jie Shao; Chen-Gang Zhu; Lu Xue; Yun-Bo Shi; Wen-Xin Li
Journal:  J Biol Chem       Date:  2008-03-28       Impact factor: 5.157

4.  Computational promoter analysis of mouse, rat and human antimicrobial peptide-coding genes.

Authors:  Manisha Brahmachary; Christian Schönbach; Liang Yang; Enli Huang; Sin Lam Tan; Rajesh Chowdhary; S P T Krishnan; Chin-Yo Lin; David A Hume; Chikatoshi Kai; Jun Kawai; Piero Carninci; Yoshihide Hayashizaki; Vladimir B Bajic
Journal:  BMC Bioinformatics       Date:  2006-12-18       Impact factor: 3.169

5.  Analgesic Neural Circuits Are Activated by Electroacupuncture at Two Sets of Acupoints.

Authors:  Man-Li Hu; Zheng-Ying Qiu; Kuang Hu; Ming-Xing Ding
Journal:  Evid Based Complement Alternat Med       Date:  2016-06-27       Impact factor: 2.629

6.  The Expression Patterns of c-Fos and c-Jun Induced by Different Frequencies of Electroacupuncture in the Brain.

Authors:  Zheng-Ying Qiu; Yi Ding; Lu-Ying Cui; Man-Li Hu; Ming-Xing Ding
Journal:  Evid Based Complement Alternat Med       Date:  2015-09-29       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.